Company Profile For Pfizer Inc.

Pfizer Inc. (PFE.N) (New York Stock Exchange)
sector: Healthcare · industry: Pharmaceuticals - Diversified ·
As of  9 Feb 2010
17.88USD
Price Change
+0.04
Percent Change
+0.22%
 
 
Research a stock:   symbol lookup

Overview

Pfizer, Inc. is a research-based, global pharmaceutical company. The Company discovers, develops, manufactures and markets medicines for humans and animals. Pfizer operates in two business segments, pharmaceutical, which includes prescription pharmaceuticals for treating cardiovascular diseases, infectious diseases, central nervous system disorders, diabetes, erectile dysfunction, allergies, arthritis and other disorders, as well as non-prescription self-medications, and animal health, which includes anti-parasitic, anti-infective and anti-inflammatory medicines and vaccines for livestock, poultry and companion animals. The Company's prescription medication product brands include Norvasc, Cardura, Zithromax, Difulcan, Zoloft, Viagra, Zyrtek, Procardia XL and Glucotrol XL. Some of the Company's non-prescription medication brands include Visine, BenGay, Cortizone, Rid, Desitin, Unisom, Plax and Barbasol. Some animal health products include Revolution, Rimadyl, Vanguard and Anipryl.

Quick Financial Synopsis

BRIEF: Pfizer is a research-based, global pharmaceutical company which discovers, develops, manufactures and markets innovative medicines for humans and animals. For the 3 months ended 4/2/00, total revenues rose 10% to $4.32B. Net income rose 45% to $1.18B. Revenues reflect increased product alliance revenue and increased sales volumes of in-line products. Earnings reflect a $135M gain on sale of reasearch-related equity investments.

Company Address

Pfizer Inc.
235 East 42nd Street
New York   NY   10017
P: +1212.5732323
F: +1212.5737851

Total Employees

50900

Company Web Links

Find Out More About PFE.N

Market Update

  • UKUK
  • USUS
  • Europe
  • Asia
  • UK Most Actives